Agile Therapeutics reported 234K in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Adma Biologics ADMA:US $ 3.66M 3.28M
Agile Therapeutics AGRX:US 234K 1.66M
Bayer BAYN:GR 7.43B 1.54B
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Johnson & Johnson JNJ:US $ 15828M 1021M
Merk MRK:US $ 10567M 873M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Pfizer PFE:US $ 15651M 1516M
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M